Boxed Warning
Caution: do not use if imprinted seal under cap is broken or missing.
The following Structured Product Label (SPL) was submitted to the FDA by Apnar Pharma Lp for the product Guaifenesin (NDC 24689-144). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding boxed warning, otc - active ingredient, otc - purpose, indications & usage, warnings, otc - keep out of reach of children, dosage & administration, storage and handling, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Caution: do not use if imprinted seal under cap is broken or missing.
Active Ingredient (per tablet)
Guaifenesin USP 400 mg
Purpose
Expectorant
Use
Warnings
Ask doctor before use if you have
Stop use and ask a doctor if
A persistent cough may be a sign of a serious condition
If pregnant or breast-feeding, ask a healthcare professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact Poison Control Center immediately.
Directions
Do not exceed 6 doses in a 24 hour period or as directed by a doctor
Other Information
Store at 15°-30°C (59°-86°F)
Inactive Ingredients
Maltodextrin, Povidone, Silicon dioxide and Stearic acid
Questions or concerns?
Manufactured by:
APNAR PHARMA LLP
East Windsor, NJ 08520
Made in USA
Rev.: 05/2022
NDC 24689-144-01
Guaifenesin Tablets 400 mg
Expectorant
100 Tablets
* Please review the disclaimer below.